182 related articles for article (PubMed ID: 36229503)
1. Longitudinal bioluminescence imaging to monitor breast tumor growth and treatment response using the chick chorioallantoic membrane model.
Javed S; Soukhtehzari S; Fernandes N; Williams KC
Sci Rep; 2022 Oct; 12(1):17192. PubMed ID: 36229503
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab Modulation of the Interaction Between the MCF-7 Cell Line and the Chick Embryo Chorioallantoic Membrane.
Comşa Ş; Popescu R; Avram Ş; Ceaușu RA; Cîmpean AM; Raica M
In Vivo; 2017; 31(2):199-203. PubMed ID: 28358700
[TBL] [Abstract][Full Text] [Related]
3. The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.
Ribatti D; Tamma R
J Cell Physiol; 2018 Jan; 234(1):152-157. PubMed ID: 30078179
[TBL] [Abstract][Full Text] [Related]
4. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
[TBL] [Abstract][Full Text] [Related]
5. An assay for cancer stem cell-induced angiogenesis on chick chorioallantoic membrane.
Nawara HM; Afify SM; Hassan G; Zahra MH; Atallah MN; Seno A; Seno M
Cell Biol Int; 2021 Apr; 45(4):749-756. PubMed ID: 33274828
[TBL] [Abstract][Full Text] [Related]
6. Chorioallantoic membrane vascularization. A meta-analysis.
Ribatti D; Tamma R; Annese T
Exp Cell Res; 2021 Aug; 405(2):112716. PubMed ID: 34186097
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
[TBL] [Abstract][Full Text] [Related]
8. Methods for Analyzing Tumor Angiogenesis in the Chick Chorioallantoic Membrane Model.
Ames JJ; Henderson T; Liaw L; Brooks PC
Methods Mol Biol; 2016; 1406():255-69. PubMed ID: 26820962
[TBL] [Abstract][Full Text] [Related]
9. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
[TBL] [Abstract][Full Text] [Related]
10. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
Tufan AC; Satiroglu-Tufan NL
Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
[TBL] [Abstract][Full Text] [Related]
11. High-resolution MRI analysis of breast cancer xenograft on the chick chorioallantoic membrane.
Zuo Z; Syrovets T; Genze F; Abaei A; Ma G; Simmet T; Rasche V
NMR Biomed; 2015 Apr; 28(4):440-7. PubMed ID: 25711154
[TBL] [Abstract][Full Text] [Related]
12. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
[TBL] [Abstract][Full Text] [Related]
13. The chick embryo chorioallantoic membrane as an experimental model to study in vivo angiogenesis in glioblastoma multiforme.
Ribatti D
Brain Res Bull; 2022 May; 182():26-29. PubMed ID: 35143927
[TBL] [Abstract][Full Text] [Related]
14. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
Ribatti D
Rom J Morphol Embryol; 2008; 49(2):131-5. PubMed ID: 18516317
[TBL] [Abstract][Full Text] [Related]
15. Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules.
Deryugina EI; Quigley JP
Methods Enzymol; 2008; 444():21-41. PubMed ID: 19007659
[TBL] [Abstract][Full Text] [Related]
16. Targeting neovascularization and respiration of tumor grafts grown on chick embryo chorioallantoic membranes.
Ademi H; Shinde DA; Gassmann M; Gerst D; Chaachouay H; Vogel J; Gorr TA
PLoS One; 2021; 16(5):e0251765. PubMed ID: 33999935
[TBL] [Abstract][Full Text] [Related]
17. Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids.
Laborda-Illanes A; Sánchez-Alcoholado L; Castellano-Castillo D; Boutriq S; Plaza-Andrades I; Aranega-Martín L; Peralta-Linero J; Alba E; González-González A; Queipo-Ortuño MI
Biomed Pharmacother; 2023 Jan; 157():114041. PubMed ID: 36423543
[TBL] [Abstract][Full Text] [Related]
18. Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.
Kennedy DC; Coen B; Wheatley AM; McCullagh KJA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008876
[TBL] [Abstract][Full Text] [Related]
19. The chick embryo chorioallantoic membrane as a model for tumor biology.
Ribatti D
Exp Cell Res; 2014 Nov; 328(2):314-24. PubMed ID: 24972385
[TBL] [Abstract][Full Text] [Related]
20. Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.
Chu PY; Koh AP; Antony J; Huang RY
Cells Tissues Organs; 2022; 211(2):222-237. PubMed ID: 33780951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
